Ranolazine Tablet, Film Coated, Extended Release
Product Images NDC 82804-118

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ranolazine (NDC 82804-118). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Ranolazine 01)

Chemical structure diagram of ranolazine, illustrating its molecular arrangement with labeled bonds and atoms typical for this active pharmaceutical ingredient.*

FDA Label Image

82804-118-60 (Ranolazine 02)

Label for Ranolazine 500 mg extended-release tablets, film-coated and oblong-shaped, with identifying markings "423" on one side and "SG" on the other. The label indicates a quantity of 60 tablets, labeled by Proficient Rx LP, manufactured by ScieGen Pharmaceuticals, Inc. in Hauppauge, NY. Storage instructions and warnings about swallowing the tablets whole are included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.